Document Detail

Predictors of left ventricular dysfunction in patients with Takayasu's or giant cell aortitis.
MedLine Citation:
PMID:  15675134     Owner:  NLM     Status:  MEDLINE    
OBJECTIVES: The aim of this study was to determine the clinical and angiographic predictors of left ventricular systolic dysfunction (LVSD) from a relatively large and angiographically characterized Takayasu's or Giant Cell aortitis (TA/GCA) population. BACKGROUND: LVSD in patients with TA/GCA has been described in case reports and attributed variously to hemodynamic and immunologic factors. The predictors of LVSD in patients with angiographically confirmed TA/GCA are not known. METHODS: We identified 78 patients with angiographically confirmed TA/ GCA that underwent transthoracic echocardiography (TTE) at Mayo Clinic. Echocardiograms were then reviewed independently by reviewers blinded to clinical and angiographic data. LVSD was defined as an ejection fraction (LVEF) less than 50%. RESULTS: The study population was 84% Caucasian (54/78), 91% female (58/78), and had a mean age of disease onset of 30 years (+/- 15 years). LVSD was present in 14 of 78 patients (18%) with TA/GCA. The mean LVEF in the LVSD group (n = 14) was 37% +/- 7%, compared to an LVEF of 62% +/- 6% (p < 0.0001) in those without LVSD (n = 64). LVSD was not associated with hypertension or aortic regurgitation (p > 0.5). However, LVSD was found in 43% (9/21) of patients with aortic arch involvement, versus only 9% (5/57) of patients without aortic arch involvement (p = 0.0013). Patients with LVSD had a median of 2 (range 1-4) involved aortic segments compared to a median of 1 (range 1-4) among those without LVSD (p = 0.013). CONCLUSIONS: In TA/GCA aortitis, LVSD is associated with involvement of the aortic arch and with the greater extent of aortic involvement. The hemodynamic variables, aortic regurgitation and systemic hypertension, were not associated with LVSD, consistent with reports that cardiac inflammation is responsible for LVSD in a majority of cases. Ours is the first study to estimate an incidence of LVSD in patients with TA/GCA aortitis, which was 18%.
D H Pfizenmaier; F O Al Atawi; Y Castillo; K Chandrasekaran; L T Cooper
Related Documents :
21095294 - Surgical treatment of ruptured aneurysm of the left sinus of valsalva caused by takayas...
29274 - Takayasu arteritis and renovascular hypertension in childhood.
677364 - Schistosomiasis and anterior spinal artery occlusion.
19077714 - Imaging for large-vessel vasculitis.
18455554 - Successful intra-arterial alteplase infusion is a predictor of 12-month limb survival i...
7314004 - Catheter tip cultures on open-heart surgery patients: associations with site of cathete...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Clinical and experimental rheumatology     Volume:  22     ISSN:  0392-856X     ISO Abbreviation:  Clin. Exp. Rheumatol.     Publication Date:  2004  
Date Detail:
Created Date:  2005-01-28     Completed Date:  2005-03-29     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8308521     Medline TA:  Clin Exp Rheumatol     Country:  Italy    
Other Details:
Languages:  eng     Pagination:  S41-5     Citation Subset:  IM    
Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota 55905, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Giant Cell Arteritis / complications*,  pathology,  physiopathology
Minnesota / epidemiology
Retrospective Studies
Single-Blind Method
Takayasu Arteritis / complications*,  pathology,  physiopathology
Ventricular Dysfunction, Left / epidemiology,  etiology*,  pathology

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Antineutrophil cytoplasmic autoantibodies penetrate into human polymorphonuclear leukocytes and modi...
Next Document:  Clinical manifestations of Behçet's disease in 137 Italian patients: results of a multicenter study...